CD8A and colorectal cancer: A significantly higher fraction of activated cytotoxic CD8 TIL in colorectal cancer patients indicated that the degree of T cell penetration into the tumor was directly related to treatment success and suggested that immunological editing could inhibit tumor growth (26).